Cargando…
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications
Reports of widespread thromboses and disseminated intravascular coagulation (DIC) in patients with coronavirus disease 19 (COVID-19) have been rapidly increasing in number. Key features of this disorder include a lack of bleeding risk, only mildly low platelet counts, elevated plasma fibrinogen leve...
Autores principales: | Merrill, Joan T., Erkan, Doruk, Winakur, Jerald, James, Judith A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391481/ https://www.ncbi.nlm.nih.gov/pubmed/32733003 http://dx.doi.org/10.1038/s41584-020-0474-5 |
Ejemplares similares
-
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
por: Erkan, Doruk, et al.
Publicado: (2016) -
Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19
por: Rodríguez, Cristina, et al.
Publicado: (2021) -
COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia
por: Teo, Shyh Poh
Publicado: (2021) -
Should COVID-19 be branded to viral thrombotic fever?
por: Costa-Filho, Rubens Carmo, et al.
Publicado: (2021) -
A call for vigilance: thrombotic thrombocytopenic syndrome caused by mRNA COVID-19 vaccine associated with muscle weakness
por: Kim, Chul Soo, et al.
Publicado: (2022)